• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Localization of a metal-dependent epitope to the amino terminal residues 33-40 of human factor IX.

作者信息

Cheung W F, Wolberg A S, Stafford D W, Smith K J

机构信息

Department of Biology, University of North Carolina, Chapel Hill 27599, USA.

出版信息

Thromb Res. 1995 Dec 1;80(5):419-27. doi: 10.1016/0049-3848(95)00194-v.

DOI:10.1016/0049-3848(95)00194-v
PMID:8588203
Abstract

Metal binding sites within the Gla domain of vitamin K-dependent coagulation factors have been divided into nonspecific metal sites and calcium-specific sites. We demonstrate here that five residues within the Gla domain of factor IX are responsible for the reactivity with the metal-dependent factor IX monoclonal antibody, A-7. First we demonstrate that modifying any one of three residues within this site in factor IX abolishes the binding of A-7. To confirm the specificity of the antibody, the Gla domain of factor VII was changed at residues 32, 33, 34, 38 and 39 to the homologous residues of human factor IX. These changes were sufficient to generate a factor VII Gla domain with an A-7 binding site of the same affinity as that in factor IX. The site identified is one of the two major surfaces of the Gla domain and may represent the metal-dependent binding site.

摘要

相似文献

1
Localization of a metal-dependent epitope to the amino terminal residues 33-40 of human factor IX.
Thromb Res. 1995 Dec 1;80(5):419-27. doi: 10.1016/0049-3848(95)00194-v.
2
Localization of a calcium-dependent epitope to the amino terminal region of the Gla domain of human factor IX.
Thromb Res. 1996 Jan 1;81(1):65-73. doi: 10.1016/0049-3848(95)00214-6.
3
Role of the propeptide and gamma-glutamic acid domain of factor IX for in vitro carboxylation by the vitamin K-dependent carboxylase.凝血因子IX的前肽和γ-谷氨酸结构域在维生素K依赖性羧化酶体外羧化作用中的作用。
Biochemistry. 1998 Sep 22;37(38):13262-8. doi: 10.1021/bi981031y.
4
Derivatives of blood coagulation factor IX contain a high affinity Ca2+-binding site that lacks gamma-carboxyglutamic acid.凝血因子IX的衍生物含有一个缺乏γ-羧基谷氨酸的高亲和力钙离子结合位点。
J Biol Chem. 1984 May 10;259(9):5698-704.
5
Structural requirements for Ca2+ binding to the gamma-carboxyglutamic acid and epidermal growth factor-like regions of factor IX. Studies using intact domains isolated from controlled proteolytic digests of bovine factor IX.
J Biol Chem. 1991 Feb 5;266(4):2430-7.
6
gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.γ-羧基谷氨酸36和40对人凝血因子IX的功能没有贡献。
Protein Sci. 1997 Jan;6(1):185-96. doi: 10.1002/pro.5560060121.
7
Characterization of gamma-carboxyglutamic acid residue 21 of human factor IX.人凝血因子IX第21位γ-羧基谷氨酸残基的特性分析
Biochemistry. 1996 Aug 13;35(32):10321-7. doi: 10.1021/bi960502i.
8
Localization of an epitope of a calcium-dependent monoclonal antibody to the N-terminal region of the Gla domain of human factor VII.一种钙依赖性单克隆抗体的表位在人因子VII Gla结构域N端区域的定位。
Thromb Res. 1995 Jul 15;79(2):199-206. doi: 10.1016/0049-3848(95)00105-z.
9
The endothelial cell binding determinant of human factor IX resides in the gamma-carboxyglutamic acid domain.
Biochemistry. 1992 Feb 18;31(6):1806-8. doi: 10.1021/bi00121a031.
10
Factor IX Zutphen: a Cys18-->Arg mutation results in formation of a heterodimer with alpha 1-microglobulin and the inability to form a calcium-induced conformation.凝血因子IX祖芬:半胱氨酸18突变为精氨酸导致与α1-微球蛋白形成异二聚体,并无法形成钙诱导构象。
Biochem J. 1995 Nov 1;311 ( Pt 3)(Pt 3):753-9. doi: 10.1042/bj3110753.

引用本文的文献

1
Characterization of missense mutations in the signal peptide and propeptide of FIX in hemophilia B by a cell-based assay.通过基于细胞的检测方法对B型血友病中FIX信号肽和前肽错义突变的特征分析
Blood Adv. 2020 Aug 11;4(15):3659-3667. doi: 10.1182/bloodadvances.2020002520.
2
Engineering of a membrane-triggered activity switch in coagulation factor VIIa.工程化凝血因子 VIIa 的膜触发活性开关。
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12454-12459. doi: 10.1073/pnas.1618713114. Epub 2017 Nov 6.
3
Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX.
关节内因子IX蛋白或基因替代在缺乏循环因子IX的情况下可预防血友病性滑膜炎的发展。
Blood. 2008 Dec 1;112(12):4532-41. doi: 10.1182/blood-2008-01-131417. Epub 2008 Aug 20.
4
gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function.γ-羧基谷氨酸36和40对人凝血因子IX的功能没有贡献。
Protein Sci. 1997 Jan;6(1):185-96. doi: 10.1002/pro.5560060121.